Takeda Sees Another Wave 1 Plan Come Crashing Down

 
• By Joseph Haas
  
Leukemia
Takeda's NEDD8 inhibitor failed a Phase III study in MDS and leukemia
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D